{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:30:21Z","timestamp":1765546221807},"reference-count":32,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.vaccine.2017.06.050","type":"journal-article","created":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T15:16:08Z","timestamp":1498749368000},"page":"4088-4093","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Influenza vaccines effectiveness 2013\u201314 through 2015\u201316, a test-negative study in children"],"prefix":"10.1016","volume":"35","author":[{"given":"Heather L.","family":"Valdin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodolfo E.","family":"B\u00e9gu\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.06.050_b0005","unstructured":"Centers for Disease Control and Prevention. Disease burden of influenza. Available at: <http:\/\/www.cdc.gov\/flu\/about\/disease\/burden.htm>. [accessed October 11, 2016]."},{"issue":"32","key":"10.1016\/j.vaccine.2017.06.050_b0010","first-page":"691","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) \u2013 United States, 2014\u20132015 influenza season","volume":"63","author":"Grohskopf","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2017.06.050_b0015","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jpids\/piv041","article-title":"Immunogenicity and safety of an inactivated quadrivalent influenza vaccine in US children 6\u201335 months of age during 2013\u20132014: results from a phase II randomized trial","volume":"5","author":"Wang","year":"2016","journal-title":"J Pediatr Infect Dis Soc"},{"issue":"11","key":"10.1016\/j.vaccine.2017.06.050_b0020","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.vaccine.2011.12.098","article-title":"Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine","volume":"30","author":"Reed","year":"2012","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.vaccine.2017.06.050_b0025","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/j.vaccine.2013.02.053","article-title":"The test-negative design for estimating influenza vaccine effectiveness","volume":"31","author":"Jackson","year":"2013","journal-title":"Vaccine"},{"issue":"30","key":"10.1016\/j.vaccine.2017.06.050_b0030","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1016\/j.vaccine.2013.04.026","article-title":"The case test-negative design for studies of the effectiveness of influenza vaccine","volume":"31","author":"Foppa","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.06.050_b0035","unstructured":"Alere Binax NOW\u00ae Influenza A & B Card (product insert). Alere Scarborough, Inc., Maine; 2015. Available at: <http:\/\/www.alere.com\/en\/home\/product-details\/binaxnow-influenza-a-and-b.html> [accessed October 11, 2016]."},{"key":"10.1016\/j.vaccine.2017.06.050_b0040","unstructured":"FilmArray\u00ae Respiratory Panel, Biom\u00e9rieux, France. Available at: <http:\/\/www.biomerieux-diagnostics.com\/filmarray-respiratory-panel> [accessed October 11, 2016]."},{"key":"10.1016\/j.vaccine.2017.06.050_b0045","unstructured":"Louisiana Immunization Network for Kids Statewide (LINKS). Available at: <https:\/\/linksweb.oph.dhh.louisiana.gov\/linksweb\/main.jsp> [accessed October 11, 2016]."},{"issue":"49","key":"10.1016\/j.vaccine.2017.06.050_b0050","first-page":"1005","article-title":"Progress in immunization information systems \u2013 United States, 2012","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2017.06.050_b0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/ije\/13.1.87","article-title":"Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies","volume":"13","author":"Smith","year":"1984","journal-title":"Int J Epidemiol"},{"issue":"22","key":"10.1016\/j.vaccine.2017.06.050_b0060","first-page":"483","article-title":"Influenza activity \u2013 United States, 2013\u201314 season and composition of the 2014\u201315 influenza vaccines","volume":"63","author":"Epperson","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"21","key":"10.1016\/j.vaccine.2017.06.050_b0065","first-page":"583","article-title":"Influenza activity \u2013 United States, 2014\u201315 season and composition of the 2015\u201316 influenza vaccine","volume":"64","author":"Appiah","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"22","key":"10.1016\/j.vaccine.2017.06.050_b0070","doi-asserted-by":"crossref","first-page":"567","DOI":"10.15585\/mmwr.mm6522a3","article-title":"Influenza activity \u2013 United States, 2015\u201316 season and composition of the 2016\u201317 influenza vaccine","volume":"65","author":"Davlin","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"10.1016\/j.vaccine.2017.06.050_b0075","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/cid\/ciw635","article-title":"2014\u20132015 influenza vaccine effectiveness in the United States by vaccine type","volume":"63","author":"Zimmerman","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2017.06.050_b0080","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/infdis\/jiw181","article-title":"Enhanced genetic characterization of influenza A(H3N2) viruses and vaccine effectiveness by genetic group, 2014\u20132015","volume":"214","author":"Flannery","year":"2016","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2017.06.050_b0085","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/cid\/ciw432","article-title":"Influenza vaccine effectiveness against antigenically drifted influenza higher than expected in hospitalized adults: 2014\u20132015","volume":"63","author":"Petrie","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"26","key":"10.1016\/j.vaccine.2017.06.050_b0090","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa1215817","article-title":"Vaccine for prevention of mild and moderate-to-severe influenza in children","volume":"369","author":"Jain","year":"2013","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.vaccine.2017.06.050_b0095","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199805143382002","article-title":"The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children","volume":"338","author":"Belshe","year":"1998","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2017.06.050_b0100","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1542\/peds.2006-0725","article-title":"Safety, efficacy and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care","volume":"118","author":"Vesikari","year":"2006","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.vaccine.2017.06.050_b0105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1750-2659.2010.00183.x","article-title":"The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults","volume":"5","author":"Ambrose","year":"2011","journal-title":"Influenza Other Respi Viruses"},{"issue":"7","key":"10.1016\/j.vaccine.2017.06.050_b0110","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJMoa065368","article-title":"Live attenuated versus inactivated influenza vaccine in infants and young children","volume":"356","author":"Belshe","year":"2007","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.vaccine.2017.06.050_b0115","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/01.inf.0000237797.14283.cf","article-title":"Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma","volume":"25","author":"Fleming","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.vaccine.2017.06.050_b0120","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/01.inf.0000237829.66310.85","article-title":"Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections","volume":"25","author":"Ashkenazi","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"15","key":"10.1016\/j.vaccine.2017.06.050_b0125","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.vaccine.2013.12.069","article-title":"Live attenuated influenza vaccine strains elicit a greater innate immune response than antigenically-matched seasonal influenza viruses during infection of human nasal epithelial cell cultures","volume":"32","author":"Fischer","year":"2014","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2017.06.050_b0130","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/infdis\/jiw230","article-title":"Live attenuated influenza vaccine in children induces B-cell responses in tonsils","volume":"214","author":"Mohn","year":"2016","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2017.06.050_b0135","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/INF.0b013e31825687b0","article-title":"Immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in children","volume":"31","author":"Block","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.06.050_b0140","unstructured":"MedImmune. FluMist Quadrivalent (package insert). Gaithersburg, MD: MedImmune; 2016. Available at: <http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/ApprovedProducts\/UCM294307.pdf> [accessed October 11, 2016]."},{"issue":"10","key":"10.1016\/j.vaccine.2017.06.050_b0145","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/infdis\/jiv577","article-title":"Influenza vaccine effectiveness against 2009 pandemic influenza A(H1N1) virus differed by vaccine type during 2013\u20132014 in the United States","volume":"213","author":"Gaglani","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.06.050_b0150","unstructured":"Centers for Disease Control and Prevention. Seasonal influenza vaccine effectiveness; 2005\u20132016. Available at: <http:\/\/www.cdc.gov\/flu\/professionals\/vaccination\/effectiveness-studies.htm>. [accessed October 11, 2016]."},{"key":"10.1016\/j.vaccine.2017.06.050_b0155","doi-asserted-by":"crossref","unstructured":"Grohskopf LA, Sokolow LZ, Broder KR, Olsen SJ, Karron RA, Jernigan DB, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices \u2013 United States, 2016\u201317 influenza season. MMWR Recomm Rep 2016;65(RR-5):1\u201351.","DOI":"10.15585\/mmwr.rr6505a1"},{"issue":"1","key":"10.1016\/j.vaccine.2017.06.050_b0160","doi-asserted-by":"crossref","first-page":"e1003831","DOI":"10.1371\/journal.ppat.1003831","article-title":"A single amino acid in the stalk region of the H1N1pdm influenza virus HA protein affects viral fusion, stability and infectivity","volume":"10","author":"Cotter","year":"2014","journal-title":"PLoS Pathog"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17308472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17308472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T08:20:05Z","timestamp":1535703605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17308472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":32,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0264410X17308472"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.06.050","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influenza vaccines effectiveness 2013\u201314 through 2015\u201316, a test-negative study in children","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.06.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}